Helium-3 magnetic resonance imaging of treatment response in exercise induced bronchoconstriction

S. Fain, G. Parraga, B. Dardzinski, M. Ruddy, A. Harman, L. Mixson, S. Nagle, S. Choy, C. Francois, D. Niles, S. Kruger, R. Burton, N. Jarjour, D. McCormack (Madison, Whitehouse Station, United States Of America; London, Canada)

Source: Annual Congress 2010 - State of the art imaging
Session: State of the art imaging
Session type: E-Communication Session
Number: 5287
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Exercise-induced bronchoconstriction (EIB) is characterized by heterogeneous airway obstruction in response to physical exercise. Prophylactic drug therapies depend on the duration and characterization of their bronchoprotective effect. Images of ventilation on hyperpolarized helium-3 (He-3) MRI can be used as an end-point for regional therapy response.
13 subjects with EIB were studied with He-3 MRI in a 3-period placebo-controlled double-blind design; 2 placebo, and 1 treatment with oral Montelukast 10 mg (Merck, Whitehouse Station, NJ). MRI was performed at 30 min prior to dosing, and 3 hours later at 10, and 45 min post-exercise challenge. Image end-points included ventilated volume (VV) and defect number by lung lobe, both compared to FEV1.
Inter-rater agreement with the intra-class correlation coefficient was 0.85 for VV and 0.91 for defect number. Large ventilation defects observed after exercise challenge resolved after treatment in 10 of 13 subjects (77%).

The postchallenge FEV1 dropped 19±12% after placebo compared to 3±7% after treatment (p<0.001). Postchallenge VV dropped 10±12% after placebo compared to 3±8% after treatment (p=0.046). Lung lobes responded equally to challenge after placebo on MRI, but upper lobes were more responsive after treatment (p = 0.0042).
Lung VV on MRI showed similar response to treatment as FEV1, but MRI revealed regional responses not detected by conventional methods.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Fain, G. Parraga, B. Dardzinski, M. Ruddy, A. Harman, L. Mixson, S. Nagle, S. Choy, C. Francois, D. Niles, S. Kruger, R. Burton, N. Jarjour, D. McCormack (Madison, Whitehouse Station, United States Of America; London, Canada). Helium-3 magnetic resonance imaging of treatment response in exercise induced bronchoconstriction. Eur Respir J 2010; 36: Suppl. 54, 5287

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019



Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=325
Year: 2004

What is the minimal clinically important difference for helium-3 magnetic resonance imaging ventilation defects?
Source: Eur Respir J, 51 (6) 1800324; 10.1183/13993003.00324-2018
Year: 2018



Magnetic resonance imaging (MRI) as a non-invasive tool to assess elastase induced lung damage in spontaneously breathing rats
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Feasibility of specific ventilation imaging using oxygen enhanced magnetic resonance imaging (OEMRI) in adolescents.
Source: International Congress 2018 – Assessing pathophysiology in children
Year: 2018

Lung perfusion measured using magnetic resonance imaging
Source: Annual Congress 2012 - Functional pulmonary imaging for COPD phenotyping
Year: 2012


129Xenon-enhanced magnetic resonance imaging to understand particle exhalation from the human lung
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Predicting multiple breath washout outcomes from hyperpolarised gas magnetic resonance imaging (MRI).
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019


Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases
Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Year: 2005


Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Feasibility of spirometry-controlled chest magnetic resonance imaging (MRI) in children
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Evidence for continuous alveolisation during childhood, using 3He magnetic resonance
Source: Annual Congress 2009 - Exciting studies with old and new lung function tests
Year: 2009


Whole-body magnetic resonance imaging in extrathoracic sarcoidosis
Source: Eur Respir J 2014; 43: 1812-1815
Year: 2014


Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema
Source: Eur Respir J 2002; 19: 225-231
Year: 2002



Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009



The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008

Imaging in severe asthma
Source: Eur Respir Mon 2011; 51: 160-181
Year: 2011


Regional measures of 3D lung mechanics using magnetic resonance imaging
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012